
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.807 | 25.105 |
Price to Book | 5.230 | 3.373 |
Price to Sales | 3.491 | 3.092 |
Price to Cash Flow | 10.943 | 21.790 |
Dividend Yield | 0.539 | 1.064 |
5 Years Earnings Growth | 20.302 | 17.615 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 22.630 | 31.002 |
Industrials | 16.830 | 9.669 |
Healthcare | 13.590 | 8.546 |
Basic Materials | 10.880 | 6.754 |
Consumer Cyclical | 10.690 | 15.298 |
Consumer Defensive | 7.620 | 5.828 |
Communication Services | 6.750 | 4.548 |
Energy | 5.900 | 5.631 |
Technology | 5.120 | 10.176 |
Number of long holdings: 28
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Patanjali Foods | INE619A01035 | 5.94 | 1,777.60 | +0.44% | |
Reliance Industries | INE002A01018 | 5.90 | 1,357.20 | -2.07% | |
Bajaj Finserv | INE918I01026 | 5.57 | 1,913.50 | -0.21% | |
APL Apollo Tubes Ltd | INE702C01027 | 5.53 | 1,604.70 | +0.27% | |
Cholamandalam | INE121A01024 | 5.50 | 1,420.70 | -1.33% | |
Tata Consultancy | INE467B01029 | 5.12 | 3,084.70 | -0.29% | |
Torrent Pharma | INE685A01028 | 5.11 | 3,559.80 | -0.48% | |
Bharti Airtel | INE397D01024 | 4.65 | 1,888.80 | +0.41% | |
Bajaj Finance Ltd | INE296A01024 | 4.56 | - | - | |
Astral Ltd | INE006I01046 | 4.53 | 1,359.80 | -0.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Indian Entrepreneur Fund Retail C | 42.85M | -3.29 | 2.04 | 9.12 | ||
Indian Entrepreneur Fund Retail B | 42.85M | -0.88 | 4.30 | 8.36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review